Torrent Pharmaceuticals Reports Cessation of Independent Director Ameera Shah
Torrent Pharmaceuticals Limited has announced that Ameera Shah has completed her term and ceased to be a Director of the Company as an Independent Director. The change became effective on August 1, 2026.The completion of terms marks the end of Ms. Shah’s tenure with Torrent Pharmaceuticals Limited.
Key details regarding this cessation are presented below:
| Particulars | Details |
|---|---|
| Reason for change | Ameera Shah completed her term as an Independent Director of the Company. |
| Cessation Date | August 1, 2026 |
TORNTPHARM Stock Price Movement
Torrent Pharmaceuticals Limited soared on Friday, closing at ₹5122.8 after gaining a robust 5.50% from the previous close. The stock achieved massive momentum, trading 1.43 million shares and nearing its 52-week high amid strong market sentiment.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.